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Abstract 
Patients with chronic pain often report their cognition to be impaired by pain, and this 
observation has been supported by numerous studies measuring the effects of pain on 
cognitive task performance. Furthermore, cognitive intrusion by pain has been identified as 
one of three components of pain anxiety, alongside general distress and fear of pain. While 
cognitive intrusion is a critical characteristic of pain, no specific measure exists designed to 
captures its effects. In three studies we describe the initial development and validation of a 
new measure of pain interruption: the Experience of Cognitive Intrusion of Pain (ECIP) scale. 
In Study 1, the ECIP scale was administered to a general population sample to assess its 
structure and construct validity. In Study 2, the factor structure of the ECIP scale was 
confirmed in a large general population sample experiencing no pain, acute pain, or chronic 
pain. In Study 3 we examined the predictive value of the ECIP scale in pain related disability 
in fibromyalgia patients. ECIP scale scores followed a normal distribution with good 
variance in a general population sample. The scale had high internal reliability and a clear 
one component structure. It differentiated between chronic pain and control groups, and it 
was a significant predictor of pain related disability over and above pain intensity and pain 
catastrophizing. Repairing attentional interruption from pain may become a novel target for 
pain management interventions, both pharmacological and non-pharmacological. 
 
Summary: The Experience of Cognitive Intrusion of Pain scale was unidimensional, showed 
construct validity, differentiated fibromyalgia patients and controls, and predicted pain 
disability.  
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1. Introduction  
Patients with chronic pain report their cognition impaired by pain [3,6,29], an 
observation supported by studies of the effects of pain on task 
performance[4,9,13,14,15,17,22,26,32,38,40,64,65]. Patients also report anxiety about pain and its 
consequences, anxiety that is often cognitively intrusive. Studies that have examined the 
factor structure underlying pain anxiety have identified three core components: general 
distress, fear of pain from injury/insult, and cognitive intrusion by pain[39,41]. While our 
understanding of general distress and fear of pain is well developed, much less is known 
about cognitive intrusion.  
Cognitive intrusion may be an important determinant of pain-related distress and 
disability. In a sample of older adults with chronic low back pain, disruption to cognitive 
performance was found to mediate the relationship between pain and reduced physical 
functioning[67]. Pain interrupts by capturing attention, and directing it away from current 
concerns onto a new priority of threat detection and selection for action, typically 
characterised by attempts at avoidance or escape. Interruption involves costs to the 
performance of previously focal tasks, and is thought to be aversive. Increased attention to 
pain, or cues for pain, may increase rumination, catastrophizing, and fear of pain, 
contributing to distress and disability[31,65]. This possibility was highlighted by Mounce and 
colleagues[41], who drew a comparison between the three components of anxiety and the fear 
avoidance model, pointing out that each component may serve as a vulnerability factor for 
the development of chronic pain. 
Whilst cognitive intrusion is a critical characteristic of pain, no specific measure 
exists designed to capture its effects. We describe the initial development and validation of a 
new measure of pain interruption: the Experience of Cognitive Intrusion of Pain (ECIP) scale. 
As the intrusion of pain into consciousness is thought to occur in sequential steps[23], these 
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were used to inform the content of the scale. First, attention is re-orientated away from its 
current engagement onto pain. This stage is responsible for the ‘attention-grabbing’ function 
of pain, which serves to highlight a potentially harmful event. Second, the pain becomes a 
focus for rumination on threat. Finally, if pain and/or its threat value are not extinguished, 
pain will be difficult to disengage from[60,61].  
In Study 1, the ECIP scale was administered to a general population sample to assess 
its structure and construct validity. Although the scale items were based on a three-stage 
model of attentional disruption, the stages are inter-dependent (e.g., one cannot ruminate on 
pain before it has interrupted attention), and we therefore expected to find one component 
(Hypothesis 1). We also expected ECIP scale scores to demonstrate construct validity 
through correlations with scores on other pain-related cognition scales (Hypothesis 2). In 
Study 2, the factor structure of the ECIP scale was confirmed in a large general population 
sample. In Study 3, the ECIP scale and measures of pain-related disability were administered 
to fibromyalgia patients and matched controls. We predicted that the ECIP scale would 
differentiate between the fibromyalgia and control groups (Hypothesis 3) and have unique 
predictive value for pain-related disability in the fibromyalgia group (Hypothesis 4). 
 
2. Study 1: Development of the Experience of Cognitive Intrusion of Pain (ECIP) scale  
2.1. Method 
2.1.2. Participant characteristics 
Participants were 200 adults (150 female) aged 18 to 69 years (M = 28.08, SD = 
12.73) recruited on the internet. In particular, the study link was posted on various websites 
that advertise online studies, such as ‘Psychological Research on the Net’ 
(http://psych.hanover.edu/research/exponnet.html), on the University of Bath’s online 
noticeboard, and on the psychology department’s research participation scheme for first year 
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undergraduates. We aimed to be as inclusive as possible: our only inclusion criterion was that 
participants were aged 18 or over. 
Participants were from 18 different countries, with 99 being from the UK, 66 from the 
US, 10 from Singapore, and fewer than 5 each from the 15 other countries. The majority of 
participants reported their ethnicity as White (N = 156), with the remainder reporting Asian 
(N = 16), Black (N = 5), Mixed (N = 8) or Other (N = 15) backgrounds. English was the 
native language for 165 participants, with the remainder of participants reporting a wide 
variety of languages. Since insufficient knowledge of the English language may potentially 
affect the results, we also performed the analyses with only the native English speakers 
included. The results remained essentially the same as those reported for the full sample.  
Participants were asked to report the level of pain they were currently experiencing on 
a numerical rating scale from 0 (no pain at all) to 10 (pain could not be worse). Ratings 
ranged from 0 to 8 (Mean = 2.44, SD = 2.31, Median = 2.00) and were positively skewed (see 
Figure 1). Eighty-two participants (41%) reported being in pain at the time of the study 
(including acute pain (8%) such as migraine, and chronic pain (33%) such as fibromyalgia), 
32 (16%) also reported a second pain condition, and 12 (6%) reported having a third 
condition. Participants rated their own health as poor (N = 3), average (N = 17), good (N = 
51), very good (N = 84) or excellent (N = 45). 
 
2.1.3. Measures  
 Demographic data. Participants answered various biographical questions including 
their sex, age, native language, location and overall health. They also reported the level of 
current pain they were experiencing on a numerical rating scale from 0 (no pain at all) to 10 
(pain could not be worse) and they reported any current pain conditions they were suffering. 
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 Experience of Cognitive Intrusion of Pain scale. The new 10-item ECIP scale was 
conceptually constructed to measure the extent to which people experience pain interrupting 
their thinking. Items were designed in a top-down, theory-driven manner based on expert 
opinion from two senior authors and guided by three principles: 1) the items should be clear 
and easy to understand; 2) they should be based on the theorised effects of pain on cognition 
(initial interruption, the dominance of pain in mind when it has interrupted, and the ability or 
difficulty to control/disengage from attention to pain); and 3) there should be no content 
overlap with separate but related theoretical constructs (e.g. catastrophizing, distress). It 
should be noted that several existing scales do assess some elements of cognitive intrusion, 
although the ECIP scale is the first designed specifically to do so. For example, the Pain 
Vigilance and Awareness Questionnaire measures attention towards the physical sensations 
of pain (e.g. “I am quick to notice changes in pain intensity”) but it has only a few items 
dedicated to cognitive symptoms (e.g. ‘I notice pain even if I am busy with another activity’). 
Similarly, the Pain Anxiety Symptoms Scale contains some items related to cognitive 
symptoms of pain (e.g. “I can’t think straight when I am in pain.”), but this is not the focus of 
the scale. The Pain Catastrophizing Scale also taps into cognitive intrusion (e.g. “I can’t seem 
to keep it out of my mind”) but again it has a much broader focus. The ECIP scale was 
created to assess the phenomenology of cognitive intrusion when experiencing pain. As such, 
we did not intend to identify possible antecedents of these intrusions, or the cognitive 
processes underlying these intrusions.  
 Ten items were developed based on the three aforementioned construct markers: 
interruption by pain (3 items, e.g., “Pain interrupts my thinking”), rumination on pain (4 
items, e.g., “Pain goes around and around in my head”) and control by pain (3 items, e.g., “I 
can’t push pain out of my thoughts”). Instructions read: “We are interested in pain and 
thinking. Please tell us how far the following statements describe your experience when you 
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are in pain. How applicable are they to you?” These instructions were designed to be simple 
and non-leading, and to convey that the statements refer to experiences during episodes of 
actual pain, not thoughts of pain in general. Participants indicated the extent to which each of 
the 10 statements applied to themselves on a 7-point Likert scale ranging from 0 (not at all 
applicable) to 6 (highly applicable). Scores were summed to create total scores ranging from 
0 to 60. 
 Pain Catastrophizing Scale (PCS). The PCS[55] consists of 13 items that describe 
thoughts and feelings that individuals may have while in pain. Participants indicated the 
extent to which they experience each thought or feeling when they are in pain on a 5 point 
scale, ranging from 0 (not at all) to 4 (all the time). The scale provides a total score and 
scores on three subscales: rumination (e.g. “I can’t seem to keep it out of my mind”), 
magnification (e.g. “I wonder whether something serious may happen”), and helplessness 
(e.g. “It’s awful and I feel that it overwhelms me”)[59]. This scale has shown good reliability 
and validity[59]. In the present study, Cronbach’s alpha was .94 for the total score, .93 for the 
rumination subscale, .72 for the magnification subscale and .91 for the helplessness subscale. 
 Pain Vigilance and Awareness Questionnaire (PVAQ). The PVAQ[36] contains 16 
items that measure attention towards and vigilance for pain sensations (e.g., “I notice pain 
even if I am busy with another activity”). Participants rate the extent to which each statement 
is true of themselves when in pain on a 6 point scale from 0 (never) to 5 (always). Total 
scores range from 0 to 80. The PVAQ has been shown to be valid and reliable in both healthy 
populations and chronic pain patients[49,50]. Cronbach’s alpha of the PVAQ in this study was 
.88. 
 Pain Anxiety Symptoms Scale 20 (PASS-20). The 20-item PASS-20[37] measures 
pain-related fear and anxiety on four subscales: fear (e.g., “When I feel pain, I am afraid that 
something terrible will happen”), cognitive (e.g. “I can’t think straight when I am in pain”), 
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escape/avoidance (e.g. “I avoid important activities when I hurt”) and physiological (e.g. 
“When I sense pain I feel dizzy or faint”). Participants rate how often they engage in each 
thought or activity on a 0 (never) to 5 (always) scale. The PASS has been found to be 
reliable[1,48]. Cronbach’s alpha of the fear, cognitive, escape/avoidance and physiological 
subscales were .86, .92, .83, and .86 in the present study, respectively, and .95 for the total 
score. 
 Depression, Anxiety and Stress Scale (DASS-21). The DASS-21[35] is a 21-item 
measure of negative emotions with three subscales: depression (e.g., “I couldn’t seem to 
experience any positive feeling at all”), anxiety (e.g., “I experienced trembling”) and stress 
(e.g., “I found myself getting agitated”). Participants rate the extent to which each feeling 
applied to them in the past week on a four-point scale from 0 (never) to 3 (almost always). 
The DASS-21 is reliable in clinical and community samples[2]. In the present study the 
Cronbach’s alpha for each subscale was .88, .85, and .88 for depression, anxiety and stress, 
respectively. 
 Short Form 36 Health Survey (SF-36). The SF-36[66] is a standardised 36-item 
questionnaire used to assess eight aspects of health: 1) limitations in physical activities 
because of health problems; 2) limitations in social activities because of physical or 
emotional problems; 3) limitations in usual role activities because of physical health 
problems; 4) bodily pain; 5) general mental health (psychological distress and well-being); 6) 
limitations in usual role activities because of emotional problems; 7) vitality (energy and 
fatigue); and 8) general health perceptions. The measure is valid and reliable[8]. In the current 
study, the scale had a Cronbach’s alpha of .80.  
  
2.1.4. Procedure 
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The study was approved by the University of Bath Department of Health and 
Department of Psychology ethics committees. Participants were directed to the webpage from 
advertisements in various online locations (see ‘Participants’ section). After opening the 
webpage and giving informed consent, participants completed demographics questions and 
six scales in a set order (ECIP, PCS, PVAQ, PASS-20, DASS-21 and SF-36) using Bristol 
Online Surveys. During this online assessment, each scale was presented on a separate screen 
and participants were not able to revisit previous screens. It was necessary to answer all 
questions before progressing on to the next screen, but participants were free to withdraw 
from the study at any time. The questionnaires took 10-20 minutes to complete and 
participants were debriefed and provided with the contact details of the researchers at the end. 
 
2.1.5. Analysis 
In order to determine the structure of the ECIP Scale, the 10 items were entered into 
an exploratory factor analysis, and an internal reliability analysis. To assess the construct 
validity of the scale, scores were entered into a correlation analysis with scores on the PCS, 
PVAQ, PASS-20, DASS-21 and SF-36.  
 
2.2. Results 
2.2.1. Prevalence of pain 
Having a current pain condition was more prevalent in females (45.3%) than in males 
(28%), χ2 = 4.66, df = 1, p = .031. Sex differences in current pain intensity across the whole 
sample were investigated with a Mann-Whitney U test (given the non-normal distribution of 
pain scores). This revealed higher current pain scores in females (M = 2.61, SD = 2.32, 
Median = 2.00) than in males (M = 1.90, SD = 2.24, Median = 1.00), U(200) = 3,004, z = 
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2.14, p = .032. There was also a small positive correlation between current pain ratings and 
age, rs (200) = .20, p = .004.  
 
2.2.2. Exploratory Factor Analysis 
To examine the structure of the ECIP scale we used an exploratory factor analysis and 
extracted components with an Eigenvalue greater than 1. Ten ECIP scale items were entered 
into the principal components analysis. The first component had an Eigenvalue of 7.50, the 
second 0.65 and the third 0.47. Based on the Eigenvalues and the scree plot, it was decided 
that a one component solution was most appropriate. All 10 items loaded highly onto the first 
component, with loadings ranging from .68 to .92, suggesting that all items reflect a unitary 
cognitive intrusion concept. Table 1 displays the loadings for each item onto the first factor. 
Based on this analysis all 10 items were retained. The final scale had a Cronbach’s alpha of 
.96. 
 
2.2.3. Descriptive statistics 
Scores on the ECIP scale had a range of 0 to 60 (representing the full possible range) 
with a mean of 26.55 (SD = 15.61) and a median of 26. The data were normally distributed 
although somewhat flat (skewness = 0.149, kurtosis = -0.841, see Figure 2). ECIP scores of 
females were significantly higher (M = 28.44, SD = 15.29) than those of males (M = 20.88, 
SD = 15.33), t(198) = 3.03, p = .003, d = 0.49, 95% CI (0.17, 0.82). Scores were not 
significantly correlated with age, r(200) = .134, p = .059, and did not differ depending on 
ethnicity, F(1,193) < 1. Scores were significantly higher in participants who reported that 
they were in pain at the time of the study (M = 30.12, SD = 14.41) than those who did not (M 
= 24.07, SD = 15.99), t(198) = 2.74, p = .007. 
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2.2.4. Predictive value of ECIP in pain and health related distress 
Next we examined the construct validity of the ECIP scale.  Table 2 displays the 
correlations between ECIP scale scores and scores on the PCS, PVAQ, PASS-20, DASS-21 
and SF-36 in the participants who did and did not report a pain condition. ECIP scale scores 
were significantly correlated with current pain intensity in the pain group (r = .22), with PCS 
total and subscale scores in both groups (rs = .52 - .72), with PVAQ total and attention to 
pain scores in both groups (rs = .32 - .66), with PVAQ changes in pain scores in the pain 
group (r = .35), with PASS total and subscale scores in both groups (rs = .35 - .65), with 
DASS total and subscale scores in the no pain group (rs = .18 - .31), with SF-36 emotional 
well-being in the no pain group (r = .20), with SF-36 pain in the pain group (r = -.28) and 
with SF-36 general health in the no pain group (r = -.29). The overlap between cognitive 
intrusion from pain and other pain- and distress-related cognitions indicates concurrent 
validity in the ECIP scale, but the ECIP scale does not appear to be redundant – it was not 
multicollinear with any of the other scales used[56]. 
 
2.3. Study 1 discussion 
  The 10 ECIP scale items loaded highly onto one component (Hypothesis 1). 
Therefore all 10 items were retained. Scores on the scale were normally distributed and 
moderately correlated with measures of other pain-related cognitions (Hypothesis 2).  
 The experience of cognitive intrusion from pain appears to vary widely in the general 
population, and it was not correlated with age but was higher in females than in males. 
Current pain was also higher in females than in males, and was positively correlated with age.  
  Overall the results of Study 1 indicate that the 10-item ECIP scale has adequate 
psychometric properties and construct validity. Next, we aimed to confirm the factor structure 
in a larger online study with a general population sample. 
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3. Study 2: Confirmation of ECIP factor structure in a large general population sample 
3.1. Method 
3.1.2. Participants 
The study was run on the internet using Inquisit Web 4.0[21] for study presentation and 
data recording. One thousand and five hundred participants were recruited through Amazon 
Mechanical Turk (MTurk; www.MTurk.com). MTurk is an open online marketplace for 
recruiting individuals to complete a variety of tasks for a small fee, and can be used to obtain 
high-quality reliable research data quickly and inexpensively[10,42]. Participants recruited via 
MTurk were given a link to the study pages and paid $1 for their participation through the 
system’s in-built rewards mechanism. An additional 199 participants were recruited via pain- 
and psychology-related forums, websites and discussion groups which hosted a link to the 
study.  Participants recruited outside of MTurk did not receive $1 for their participation, but 
were informed that they could sign up for an MTurk account if they wished to receive $1. 
The inclusion criteria were that participants had to be aged 18 or over and with access to an 
internet-enabled laptop or desktop computer.  
Of the 1699 entries recorded, 20 participants were identified as having two 
submissions each. In these cases, only the first submission was included, and the 20 duplicate 
submissions were excluded. This left 1679 unique data submissions. Of these 1679 
submissions, 15 were from individuals who did not give consent to take part, and did not 
progress past the information and consent page. A further one participant reported his/her age 
as 17 and was excluded. Participants were also excluded if they indicated that they only 
wanted to browse the webpages rather than seriously participate (N = 18), if they did not 
report whether or not they were currently in pain (N = 8), if they did not provide enough 
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information to determine the duration of their pain (N = 76), or if they did not complete all 
ECIP items (N = 24). Removal of these cases resulted in a sample of 1537.    
Of these 1537 participants, 1536 reported their age (M = 34.23, SD = 11.22), 1537 
reported their sex (750 female, 776 male, 4 intersex, 4 male-to-female male, 3 female-to-male 
male), 1534 reported their gender (753 selected woman, 779 selected man and 2 selected 
trans*), 1537 reported their first language (1347 English, 63 Hindi, 8 Spanish, 6 Chinese and 
5 Bengali, with 13 participants indicating 10 other first languages, and 95 participants 
selecting ‘other’), 1537 reported their country (1302 selected the USA, 196 selected India, 10 
selected the UK and 29 selected a range of other countries), 1537 reported their ethnicity 
(1057 were White, 274 were Asian, 96 were Black, 64 were mixed, and 45 reported other or 
unknown) and finally, 1536 reported their highest qualification (680 had an undergraduate 
degree, 447 had finished high school, 198 had a Masters degree, 176 had A-level/advanced 
placement/baccalaureate qualifications, 26 had a Doctorate, 8 had completed some high 
school, and 1 had no qualifications).  
 
3.1.3. Measures 
In addition to the ECIP scale participants completed the measures listed below, 
followed by an additional cognitive task which is not reported here.   
Demographics Participants were asked to provide demographic information including 
age, sex, gender, native language, country of residence, ethnicity, and level of education.  
Pain experiences In order to ascertain current pain status, participants were asked to 
indicate whether or not they were currently in any pain as well as the intensity of this pain on 
a scale of 0 (no pain at all) to 10 (pain could not be worse). Participants were asked to 
indicate the type(s) of pain they were experiencing by selecting any applicable items from a 
list or entering any other conditions in a free text box. Participants who reported pain were 
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also asked to report the duration of their current pain using a free text box. Duration 
responses were coded into two categories: less than 3 months and 3 months or longer.  
 
3.1.4. Procedure 
The study was approved by the University of Bath Department of Health and 
Department of Psychology ethics committees. Participants were directed to the webpage from 
MTurk or advertisements in various online locations (see section ‘3.1.2. Participants’). After 
opening the webpage and giving informed consent, participants completed the demographics 
questions, the pain related questions, the ECIP scale and a subsequent cognitive task which 
was performed for the purpose of another study and is not described here. Each section was 
presented on a separate screen and participants were not able to revisit previous screens. All 
questions were optional except for reporting the current presence or absence of pain. The 
study took 10-15 minutes to complete and participants were debriefed and provided with the 
contact details of the researchers at the end. 
 
3.1.5. Analysis 
We ran a series of confirmatory factor analyses examining the one-factor structure 
found in Study 1, separately in the pain-free participants (N = 961), the participants with 
acute pain (duration < 3 months, N = 288), and the participants with chronic pain (duration > 
3 months, N = 288). We used maximum likelihood analyses and examined various measures 
of goodness-of-fit. Although chi-square is typically reported as an indicator of differences in 
fit between the hypothesised model and the data, it is often significant due to large sample 
sizes. We therefore took a goodness-of-fit index (GFI) and a comparative fit index of over 
0.90 as an indicator of acceptable fit, as well as a root mean square error of approximation 
(RMSEA) value of 0.08 or below[52]. 
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We also entered ECIP scores into a 2 (Sex: males, females) × 3 (Pain group: no pain, 
acute pain, chronic pain) ANOVA. 
 
3.2. Results 
Scores on the ECIP scale ranged from 0 to 60 (again representing the full possible 
range) with a mean of 23.94 (SD = 14.60) and a median of 23. The data were normally 
distributed (skewness = 0.270, kurtosis = -0.789, see Figure 2). ECIP scores were 
significantly higher in females (M = 24.94, SD = 14.40) than in males (M = 23.01, SD = 
14.74), t(1600) = 2.65, p = .008, although the effect size was small, d = 0.13, 95% CI (.03, 
.23).  
The results of the confirmatory factor analyses are presented in Table 3. The one 
factor solution provided an adequate fit to the data for all three groups. All GFI and CFI 
values were above .90 and all RMSEA values were below .11. 
Next we examined the effects of Sex and Pain Group on ECIP scores. A 2×3 ANOVA 
showed no main effect of Pain Group, F(2,1520) = 1.42, p = .243, a marginally significant 
effect of Sex, F(1,1520) = 3.70, p = .054, where females (M = 24.73, SD = 18.47) scored 
slightly higher than males (M = 23.03, SD = 16.02), and no interaction, F(2,1520) = 1.48, p = 
.229. 
 
3.3. Study 2 discussion 
The exploratory factor analysis in Study 1 suggested that the ECIP scale items fall on 
to one factor, and this structure was adequately confirmed in Study 2 with a confirmatory 
factor analysis. Both analyses suggest that the experience of cognitive intrusion, as measured 
by the ECIP scale, is a unitary construct. This is consistent with previous research which 
showed that cognitive intrusion, fear of pain, and general distress were each unitary 
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components of pain-related anxiety[37, 41]. In Study 3 we investigated the ECIP scale in a 
clinically diagnosed chronic pain sample and a comparison group. To further underpin the 
construct validity of the ECIP scale we additionally looked at the relationship between 
cognitive intrusion and trait anxiety, life satisfaction and emotion regulation. Furthermore we 
aimed to investigate group differences in ECIP scale scores and the unique predictive value 
of the ECIP scale in pain-related disability. 
 
4. Study 3: Experience of Cognitive Intrusion of Pain in fibromyalgia patients and 
healthy controls. 
3.1. Method 
4.1.2. Participant characteristics 
Participants were 49 fibromyalgia (FM) patients (41 females) aged 23 to 61 (M = 
45.2, SD = 9.35), and 49 control group (CG) participants (40 females) aged 22 to 65 (M = 
45.39, SD = 12.07). A majority of the participants were married or cohabiting (FM: 67.3%; 
CG: 42.9%) and almost half of the participants had graduated from high school or university 
(FM: 38.8%; CG: 53.1%). In the FM patients, the mean pain duration was 186.36 months (SD 
= 115.14) and the mean Pain Disability Index score was 41.80 (SD = 10.39). FM patients and 
healthy controls did not differ in terms of age (t(96) < 1, ns), sex ratio (χ²(1) = 0.07, ns) or 
education level (χ²(3) = 3.97, ns). All but one participant (in the healthy group) reported their 
nationality as Belgian, with the other participant being Spanish.  
 
4.1.3. Measures 
 As in Study 1, participants completed the ECIP scale and the PCS[59], as well as the 
following additional measures. All measures were presented in Dutch. The ECIP scale was 
translated and back translated to confirm accuracy. 
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 Pain experience. All participants were asked to report the current level of pain they 
were experiencing on a numerical rating scale from 0 (no pain at all) to 6 (worst pain 
imaginable), as well as average, least and worst pain over the previous week. Participants 
also rated their current extent of pain-related disability.  
Body Vigilance Scale (BVS). The BVS scale[45,51] consists of four questions and 
measures participants’ sensitivity to their internal bodily sensations e.g., “I am the kind of 
person who pays close attention to internal bodily sensations”. The last item is an average of 
the awareness scores of 15 non-specific body symptoms e.g., “Rate how much attention you 
pay to each of the following sensations”: “dizziness”, “heart palpitations”, “nausea” (0 = 
none, 10 = extreme). Scores on the BVS can vary between 0 and 40. In the present study, 
Cronbach’s alpha of the 18 BVS items was .94. 
Depression, Anxiety and Stress Scale (DASS).  The DASS[19,41]  is a 42-item 
questionnaire that measures the presence of negative emotions with three subscales: 
depression (e.g., “I felt that I had nothing to look forward to”), anxiety (e.g., “I felt I was 
close to panic”) and stress (e.g., “I found myself getting upset rather easily”). Participants rate 
the extent to which each feeling applied to them in the past week on a four-point scale from 0 
(never) to 3 (almost always). Scores for the DASS can vary between 0 and 42 for each 
subscale. The DASS has good reliability in clinical and community samples[2]. In the present 
study, Cronbach’s alpha of the DASS-subscales were .96, .91, .95 for the depression, anxiety 
and stress subscale, respectively. 
Pain Disability Index (PDI). The FM patients, but not the controls, completed the 
PDI[33,46], which measures the extent to which pain disables the participant from completing 
tasks in seven areas of life, such as self-care and social activities, each on a Likert scale of 0 
(no disability) to 10 (total disability). Scores range from 0 to 70. The reliability and validity 
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of the PDI have been well established[59]. In the present study Cronbach’s alpha of the PDI 
was .82. 
 State and Trait Anxiety Inventory-trait scale (STAI-T). Participants completed the 
STAI-T[62], which consists of 20 items each rated on a four point Likert scale. The STAI-trait 
(STAI-T) subscale measures the disposition toward anxiety as a personality trait, which is 
defined as the relatively stable individual difference in anxiety proneness. Scores for STAI-T 
can vary between 20 and 80. This questionnaire has demonstrated adequate psychometric 
properties[5]. In the present study, Cronbach’s alpha of the STAI-T was .94. 
 Satisfaction with Life Scale (SWLS). The SWLS[19,34] is a five-item measure of 
global life satisfaction (e.g., “In most ways my life is close to ideal”). Agreement with each 
item is rated on a 1-7 scale. Scores for SWLS can vary between 0 and 35 and the scale is 
valid and reliable[42]. In the present study, Cronbach’s alpha of the SWLS was .89. 
Emotion Regulation Questionnaire (ERQ). The ERQ[28,44] consists of 10 items across 
two dimensions, six to measure emotional reappraisal (e.g., “I control my emotions by 
changing the way I think about the situation I’m in”) and four to measure emotional 
suppression (e.g., “I keep my emotions to myself”). Items are rated on a 1 – 7 scale. Scores 
for ERQ can vary between 10 and 70 and the scale has adequate psychometric properties[28]. 
In the present study, Cronbach’s alpha of the ERQ reappraisal scale was .72 and of the ERQ 
suppression scale was .76. 
 
4.1.4. Procedure 
The study design was approved by the Ethics Committee of the Ghent University 
Hospital. Following ethical committee approval, participants were recruited into a larger 
study on emotional regulation and pain (the Ghent Attention and Self-regulation in 
Fibromyalgia study, ASEF-I; for a complete protocol, see http://hdl.handle.net/1854/LU-
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5686902) in Ghent, Belgium, for which they received monetary compensation.  The data 
reported here consists of questionnaire data (i.e., ECIP scale and several related 
questionnaires) collected in the context of the ASEF-I-study. FM patients were recruited via 
the Multidisciplinary Pain Clinic of the Ghent University Hospital. Inclusion criteria for the 
ASEF-I-study were: (1) being aged between 18 and 65 years; (2) having sufficient knowledge 
of the Dutch language; (3) a diagnosis of FM according to the criteria of Wolfe and 
colleagues[68] and (4) the absence of neurological conditions. Individuals were also excluded 
when they were pregnant, unable to use their fingers or when their eyesight was not normal 
or corrected-to-normal (e.g., by spectacles). These criteria were selected for the purposes of 
other aspects of the ASEF-I study, such as investigating attentional processes in pain with 
electrocutaneous stimuli, which are not relevant here.  
Although sixty-one patients were initially screened and recruited, 12 withdrew due to 
health problems, familial problems or a lack of time, leaving a sample of 49 participants with 
FM. A comparison group matched for age, sex and SES (at the group level) was invited to 
participate through a participant pool that had been recruited through advertisements in a 
local newspaper, flyers and the university website. Inclusion and exclusion criteria were the 
same as those for the chronic pain group, except that participants who reported a current pain 
problem were also excluded. A total of 82 individuals were invited to participate, and 58 
participants who met the criteria and agreed to participate were subsequently recruited into 
the study. However, nine participants withdrew due to familial issues or a lack of time, 
leaving a comparison group of 49 individuals who reported no current pain problem. 
Participants completed the questionnaires at home (demographics, PCS, BVS, PDI, 
DASS, STAI, SWLS, ERQ and ECIP), either online (via LimeSurvey 2.0; n = 95) or on 
paper (n = 3) if online assessment was not possible. Each questionnaire was presented on a 
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separate screen and all questions were compulsory. The questionnaires took approximately 45 
minutes to complete. After finishing the full ASEF-I-study, participants were debriefed. 
 
4.1.5. Analysis 
First, we compared the prevalence of pain in each group. Second, ECIP scale scores 
in the FM and matched control groups were compared with an independent samples t-test. 
Pain and ECIP scores were not compared between sexes due to the small number of males in 
each group (this is typical of FM samples). Third, to assess the relationships between the 
ECIP scale and other pain-related scales, scores were first entered into a correlation analysis 
with pain intensity, current disability due to pain, and the measures of pain-related distress, 
separately for each group. Finally, we ran a hierarchical regression model to predict PDI 
scores in the FM group from average pain intensity over the previous week in Block 1 and 
scores on the ECIP scale in Block 2, to determine whether ECIP scores predicted additional 
unique variance in disability.  
 
4.2. Results 
3.2.1. Prevalence of pain 
The FM group reported significantly more current pain (M = 3.59, SD = 1.00) than the 
control group (M = 0.45, SD = 0.89), t(96) = 16.44, p < .001, and significantly more pain over 
the past week, on average (FM: M = 3.69, SD = 1.00, control: M = 0.80, SD = 1.02), t(96) = 
14.17, p < .001. 
 
4.2.2. Cognitive intrusion in the chronic pain and control groups 
The FM group scored significantly higher on the ECIP scale (M = 19.33, SD = 13.51) 
than the control group (M = 7.45, SD = 11.86), t(96) = 4.63, p < .001, d = 0.93, 95% CI (0.51, 
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1.35). Nevertheless there was a wide range of scores in both groups: in the FM group scores 
ranged from 1 to 60 and in the control group scores ranged from 0 to 53. The scale had very 
high internal reliability in both groups, with a Cronbach’s alpha of .96 in the FM group and 
.97 in the control group.  
 
4.2.3. Predictive value of ECIP scale in disability and distress 
We examined the correlations between ECIP scale scores and pain intensity (current 
and previous week), current disability due to pain rating, PDI scores, PCS scores, DASS 
scores, BVS scores, STAI-T scores, SWLS scores and ERQ scores (see Table 4) in each 
group, with the exception of the disability scores since these measures were only 
administered to the FM group. Several observations are of note: first, ECIP scale scores were 
significantly positively correlated with ratings of current disability due to pain, r(49) = .44, p 
= .002, and with total scores on the PDI, r(49) = .44, p < .001. Second, ECIP scale scores 
were highly positively correlated with the tendency to catastrophize when in pain in the FM, 
r(49) = .78, p < .001, and control groups, r(49) = .73, p < .001. Third, higher ECIP scale 
scores were associated with higher depression, r(49) = .63, p < .001, anxiety, r(49) = .57, p < 
.001, and stress scores, r(49) = .39, p = .006, higher trait anxiety scores, r(49) = .60, p <.001, 
and lower satisfaction with life scores, r(49) = -.35, p = .013, in the FM group only. Finally, 
in both groups higher ECIP scale scores were related to higher scores on the suppression 
subscale of the emotion regulation questionnaire, but they were not related to scores on the 
reappraisal subscale.  
To formally examine the difference between groups in correlations between ECIP 
scale scores and measures of life quality, we compared the magnitudes of the correlations for 
each measure between groups using Fisher’s r-to-z transformation. The correlation between 
ECIP scale and DASS-depression scores was significantly larger in the FM group than the 
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control group, z = 3.20, p < .001. This was also the case for DASS-anxiety scores, z = 2.69, p 
= .007, and marginally so for DASS-stress scores, z = 1.86, p = .063. However the correlation 
between ECIP scale scores and satisfaction with life did not differ between groups, z = 1.23, 
p = .219, and neither did the correlation between ECIP scale scores and trait anxiety, z = 1.35, 
p = .177. 
Next, to determine whether ECIP scores predicted variance in pain disability over and 
above pain intensity, we ran a hierarchical regression model predicting PDI scores in the FM 
group from pain intensity over the past week in Block 1, and ECIP scale scores in Block 2. 
Block 1 was significant, R2 = .32, F(1,47) = 22.29, p < .001, pain intensity β = .57, and Block 
2 explained significant additional variance, ΔR2 = .08, F(1,46) = 6.07, p = .018, pain intensity 
β = .48, ECIP β = .29. 
 
4.3. Study 3 discussion 
The ECIP scale successfully differentiated between the FM and control groups with a 
large effect size, d = 0.93, in support of Hypothesis 3. Those with chronic pain experienced 
more cognitive intrusion than controls, despite there being wide variation within each group. 
The scale also demonstrated high internal reliability in both groups. ECIP scale scores were 
related to measures of pain-related disability and distress in the FM group (Hypothesis 4). 
The ECIP scale even predicted unique variance in disability over and above pain intensity in 
the past week. ECIP scale scores were related to satisfaction with life, trait anxiety and 
depression, anxiety and stress scores in the pain group. Overall, the results of Study 3 suggest 
that the ECIP scale can successfully differentiate between chronic pain and control groups, 
and that it provides unique predictive value of disability in chronic pain patients.  
 
5. General discussion 
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The ECIP scale was conceptually constructed to measure the interference component 
of pain-related cognition. Ten items were developed based on a three-stage model of 
cognitive intrusion, where pain interrupts thoughts, becomes the subject of thinking/thought, 
and becomes difficult to disengage from[60,61]. Although the items were guided by this model, 
the scale was intended to measure the experience of cognitive intrusion, not the processes 
leading to it. The ECIP scale was evaluated in three studies. First, we examined the structure 
in a general population sample and confirmed that all items loaded on a single ‘cognitive 
intrusion’ component. Scores on the ECIP scale were moderately correlated with scores on 
the PCS (highly correlated with the rumination subscale, r = .72), PVAQ, PASS, DASS and 
subsections of the SF-36 Health Scale, indicating construct validity but not redundancy. In a 
second study, we used confirmatory factor analysis on a large sample of participants who 
reported no pain, acute pain or chronic pain. The one factor solution found in Study 1 fit the 
data for all three groups. In Study 3, we administered the ECIP scale to FM patients and 
matched controls. ECIP scores were significantly higher in the FM group than the control 
group and were related to current pain intensity and pain disability in the FM group. ECIP 
scale scores predicted pain disability over and above pain intensity in the past week. 
  Our data indicated one component to the ECIP scale. This is unsurprising given that 
cognitive intrusion has emerged as a single component in previous investigations of pain-
related cognition[39,41]. This is not to say that cognitive intrusion stems from a single process, 
but the experience of it appears to be unitary. Although the items were chosen based on three 
stages of cognitive intrusion, the stages were hypothesised to be interdependent and highly 
related. Indeed, they do not appear to be mathematically separable, but it may be useful to 
differentiate between them conceptually. For example, interventions to remedy cognitive 
intrusion might focus on the rumination and dominance elements, if the interruption element 
was found to be unavoidable.  
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 DASS depression and anxiety scores were correlated with ECIP scale scores in the 
FM group but not in the control group. This could be due to a smaller range of DASS scores 
in the control group (depression: 0-25 versus 1-41 in the FM group, anxiety: 0-13 versus 0-40 
in the FM group), or because cognitive intrusion contributes to negative affect in pain 
patients. The DASS measures negative feelings over the previous week, and the same 
correlation pattern with ECIP scale scores was not true for the longer-term satisfaction with 
life or trait anxiety measures, suggesting that cognitive intrusion may contribute to short-term 
experiences of depression and anxiety in chronic pain patients.  
ECIP scale scores were moderately correlated with pain-related disability and they 
predicted unique variance in disability over and above pain intensity. However, it is of course 
impossible to test for causation in the relationship between ECIP and disability using our 
current dataset since the design was cross-sectional. Nevertheless, cognitive intrusion may 
play an important theoretical role in pain cognition that is not well captured by other 
measures (as discussed in the method, the PCS, PVAQ and PASS do touch on cognitive 
intrusion but their focus is elsewhere). For example, we might hypothesise that intrusion of 
pain into cognition allows for rumination and catastrophizing, which in turn feed into a fear 
of pain and promote avoidance and disability[47,54,59]. These data cannot support such a 
suggestion, but if cognitive intrusion were established as a determinant of pain disability then 
it may be a good target for intervention. 
Scores on the ECIP scale and the PCS were highly correlated, but we do not believe 
this to be a limitation to the ECIP scale. The PCS does not reflect catastrophizing as it is 
conceived of in other areas of psychology[30], and it has been subject to criticism[24,58], 
although this is largely ignored. We suggest that the overlap is due to impurity in the way the 
PCS measures catastrophizing, as opposed to the ECIP scale measuring catastrophizing.   
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FM patients had significantly higher scores on the ECIP scale than controls, and 
scores were correlated with pain intensity. This raises an interesting issue: does more pain 
lead to higher susceptibility to intrusion, or does higher susceptibility to intrusion lead to 
worse pain experiences, or perhaps the relationship is bidirectional as the cognitive-
perceptual model of somatic interpretation would suggest[10]. The cognitive-perceptual model 
suggests that the relationship between biological state and symptom perception is influenced 
by psychosocial factors, including attention towards internal sensations and attribution of 
causes and consequences of symptoms. We do not mean to imply that chronic pain is caused 
by susceptibility to cognitive intrusion; but perhaps once pain occurs, individual differences 
in the extent to which that pain dominates attention are related to experiences of the pain. 
Selective attention to internal bodily sensations has been identified as a significant predictor 
of symptom perception[27], and cognitive intrusion of pain may contribute in a similar fashion 
to pain symptom perception. In the bottom-up direction, more regular and/or high intensity 
pain experiences may lead to more cognitive intrusion, and there may be an interactive 
relationship between top-down and bottom-up factors. However, it should be noted that there 
was no difference in ECIP scores between the pain and no pain groups in Study 2. This may 
be due to the pain group in Study 2 being non-clinical. Further research is needed to confirm 
the discriminative validity of the ECIP scale.  
 Our findings raise the question of the role of inhibition/control in pain cognition. 
ECIP scale scores were related to the suppression subscale of the ERQ, but not the 
reappraisal subscale. The suppression scale measures the extent to which participants refrain 
from expressing their emotions, which may reflect a need for control over one’s emotions. 
Participants who scored higher on suppression also reported more cognitive intrusion. It may 
be the case that cognitive intrusion from pain is difficult to inhibit and participants who tend 
to suppress their emotions have worse subjective experiences of cognitive intrusion because 
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of the difficulty in ignoring it. This is of course speculative and should be examined 
empirically.  
There are several limitations to our studies. While a substantial proportion of 
participants in Studies 1 and 2 reported a current pain condition (41% and 35%, respectively), 
they were community-based samples, not clinic-based. Future research should confirm the 
one-factor structure of the ECIP scale in a large clinically-diagnosed pain sample. Another 
limitation is the sex ratios of our samples. In Studies 1 and 3 the number of females 
outweighed the number of males (3:1 and 4:1, respectively), limiting our capacity for sex 
comparisons (this is typical for FM samples). In Study 2 we had a well-balanced female (750) 
to male (776) ratio, which also showed higher ECIP scores in females than in males, but there 
was a high prevalence of intersex and transgender participants compared to the population. 
Overall, the sex distributions of our samples may limit the generalisability of our findings.  
A limitation of self-report scales is that they cannot discriminate between the 
processes and results of cognition. Here we were interested in participants’ experiences of 
cognitive intrusion from pain, not the processes leading to it. Finally, our data does not 
inform us on the relationship between participants’ experiences of cognitive intrusion from 
pain and the extent to which their task performance is affected by pain. This is an important 
question for future research. Participants who score high on the ECIP scale may also show 
the largest effects of pain on task performance, or the relationship may be more complex. For 
example, individual differences in coping strategies may mean that some individuals with 
high ECIP scores are able to counteract this effect and maintain their task performance. 
A focus on the interruption of attention by pain highlights its motivational function in 
displacing current concerns with a new priority, in promoting interpretation, escape and 
avoidance, and in its ability to fuel and maintain worry[16]. Extending this account to the 
removal of pain in analgesia promotes the intriguing idea of novel outcome targets for pain 
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management interventions, both pharmacological and non-pharmacological[7]. Pain 
management can be targeted at reducing the frequency, intensity, or affective experience of 
interruption, at the character, content, and valence of the rumination or on the rigidity of the 
attentional focus on pain[24]. 
In sum, we have developed a novel measure specific to the experience of cognitive 
intrusion from pain. The scale is available in English 
(http://www.bath.ac.uk/pain/assessment-tools/) and Dutch 
(http://www.ghplab.ugent.be/EN/assessment-and-research-tools). Scores followed a normal 
distribution with good variance in general population samples. The scale had high internal 
reliability and a one component structure. It differentiated between chronic pain and control 
groups, and was a significant predictor of pain-related disability.  
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Figure 1. Distribution of pain ratings in the general population sample recruited for Study 1. 
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Figure 2. Distribution of ECIP scores in the general population sample in Study 1. 
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Figure 3. Distribution of ECIP scores in the fibromyalgia and control groups in Study 3. 
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Table 1. Factor loadings for the ECIP items in Study 1. Construct marker labels are given in 
parentheses (I = interruption, C = control, R = rumination). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Item Loading 
Pain interrupts my thinking (I) .68 
I can’t stop thinking about pain (C) .90 
Pain goes around and around in my head (R) .86 
It is hard to think about anything else but pain (C) .92 
I can’t push pain out of my thoughts (C) .89 
Pain dominates my thinking (R) .92 
Pain easily captures my thinking (I) .83 
I keep thinking about pain (R) .90 
When my mind wanders it goes to pain (R) .74 
Pain intrudes on my thoughts (I) .84 
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Table 2. Correlations between measures administered in Study 1, *p<.05, **p<.01. 
  
CIP 
Current 
pain 
intensity 
  PCS rumination PCS magnification 
PCS 
helplessness PVAQ total 
PVAQ 
attention to 
pain 
PVAQ changes 
in pain PASS total 
PASS 
cognitive 
PASS 
avoidance PASS fear PASS anxiety DASS total 
DASS 
depression DASS anxiety DASS stress 
SF-36 physical 
functioning 
SF-36 
physical role 
limitations 
SF-36 
emotional role 
limitations 
SF-36 energy 
and fatigue 
SF-36 
emotional 
wellbeing 
SF-36  
functi    
 
No 
pain  Pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain    
 
    
  
Current pain 
intensity 
- .22*  
                                              
PCS total 
.70** .69** .26* 
                                              PCS 
rumination 
.72** .72** .20 
.94** .93** 
                                            PCS 
magnification 
.52** .61** .27* 
.83** .84** .68** .73** 
                                          PCS 
helplessness 
.65** .58** .25* 
.96** .95** .85** .80** .70** .71** 
                                        
PVAQ total 
.32** .60** .27* 
.34** .55** .34** .58** .36** .49** .27** .46** 
                                      PVAQ 
attention to 
pain 
.42** .66** .22 
.46** .64** .46** .65** .39** .57** .38** .56** .92** .90** 
                                    PVAQ 
changes in 
pain 
0.1 .35** .26 
0.1 .27* 0.1 .32** .23* .25* .05 .20 .85** .84** .57** .52** 
                                  
PASS total 
.54** .54** .13 
.57** .74** .57** .67** .50** .69** .58** .68** .69** .60** .77* .74** .39** .25* 
                                PASS 
cognitive 
.65** .61** .11 
.64** .75** .64** .70** .48** .66** .61** .69** .60** .61** .72** .71** .30** .31** .90** .90** 
                              PASS 
avoidance 
.47** .35** .07 
.50** .47** .50** .43** .38** .38** .46** .45** .68** .51** .73** .59** .44** .27* .87** .78** .73** .62** 
                            
PASS fear 
.41** .42** .17 
.47** .71** .47** .62** .52** .72** .55** .57** .55** .42** .62** .57** .30** .11 .90** .39** .74** .69** .68** .39** 
                          PASS 
anxiety 
.37** .40** .10 
.37** .52** .41** .49** .40** .53** .56** .58** .63** .44** .70** .58** .36** .14 .91** .58** .73** .65** .72** .58** .83** .64** 
                        
DASS total 
.30** .24* .20 
.30** .45** .32** .37** .41** .53** .43** .39** .36** .23* .41** .39** .21* -.03 .54** .37** .45** .43** .46** .37** .56** .60** .47** .55** 
                      DASS 
depression 
.29** 0.14 .18 
.29** .40** .30** .30** .39** .49** .39** .31** .31** .19 .36** .31** .16 -.02 .47** .32** .40** .42** .41** .32** .49** .55** .40** .40** .90** .91** 
                    DASS 
anxiety 
.31** 0.2 .06 
.31** .33** .29** .31** .36** .41** .43** .34** .40** .18 .43** .34** .25** -.07 .57** .32** .45** .30** .50** .32** .58** .47** .51** .55** .87** .85** .65** .62** 
                  
DASS stress 
.18* .30* .29** 
.18** .46** .26** .40** .35** .52** .35** .40** .28** .25* .30** .40** .17 -.01 .41** .36** .37** .43** .34** .36** .42** .57** .36** .53** .91** .92** .72** .77** .71** .70** 
                SF-36 
physical 
functioning 
-0.1 -0.16 -.21 
-0.1 -.21 -0.09 -.10 -.14 -.21 -.14 -.24* -.06 -.24* -.11 -.24* .03 -.16 -.16 -.18 -.10 -.17 -.19* -.18 -.17 -.17 -.13 -.02 -.135 -.27* -.14 
-
.33** -.15 -.11 -.07 -.27* 
              SF-36 
physical role 
limitations 
0.05 -0.33 -.27* 
0.05 .38** -0.05 
-
.29** -.03 
-
.40** .02 
-
.32** -.09 
-
.34** -.13 
-
.32** -.01 -.28* -.06 -.27* -.02 
-
.37** -.19* -.27* -.03 .28* .01 -.26* -.20* 
-
.38** -.23* 
-
.42** -.12 -.21 -.17 
-
.37** .28** .46** 
            SF-36 
emotional 
role 
limitations 
-0.02 -0.18 -.16 
-0.02 
-
.40** -0.03 
-
.33** -.14 
-
.38** -.08 
-
.41** -.08 -.29* -.11 
-
.41** -.01 -.06 -.06 
-
.41** -.08 
-
.41** -.04 
-
.41** -.09 
-
.47** -.002 
-
.49** 
-
.40** 
-
.62** 
-
.49** 
-
.64** -.18 
-
.41** 
-
.37** 
-
.59** -0.03 .27* .21* .37** 
          SF-36 energy 
and fatigue 
0.04 0.07 .11 
0.04 .02 0.07 -.01 .02 .05 .03 -.08 .08 -.05 .01 -.08 .16 -.01 .04 -.16 .06 -.20 .01 -.16 -.01 .06 .08 .08 .03 .02 -.05 -.09 -.01 .02 .15 .15 -0.09 .04 -.02 -.08 .03 .05 
        SF-36 
emotional 
wellbeing 
.20* 0.21 .07 
.20* .35** .22* .35** .30** .30 .23* .33** .30** .23* .26** .33** .26** .04 .25** .22* .24** 
-
.28** .22* .22* .25** .42** .20* .37** .39** .42** .42** .36** .30** .38** .31** .40** -0.2* .01 
-
.22* -.09 
-
.27** 
.-
.35** .41** .15 
      SF-36 social 
functioning -0.01 -0.21 -.19 -0.01 -.20 -0.09 -.17 -.09 -.22 -.03 -.21 -.07 -.13 -.06 -.21 -.07 .004 -.04 -.17 .05 -.20 -.12 -.17 -.04 -.25* -.02 -.28* -.16 
-
.29** -.18* 
-
.36** -.10 -.12 -.14 -.27* -.03 .30** .14 .32** .23* .46** -.04 .06 -.18* -.17 
    
SF-36 pain -0.16 -.28* -.36** 
-0.16 
-
.30** -0.11 
-
.30** -.10 -.26* -.19* -.25* 
-
.26** 
-
.28** 
-
.36** -.14 -.06 -.38* -.33 -.15 
-
.26** -.17 
-
.35** -.06 
-
.29** -.15 
-
.29** -.12 
-
.33** -.11 
-
.34** -.08 
-
.35** -.07 -.18* -.15 .10 .23* .17 .34* .25** .13 -.01 -.06 -.16 -.13 -.11  
  SF-36 
general 
health 
-
.29** -0.04 -.19 -0.29** 
-
.32** 
-
0.27** -.22* 
-
.25** -.34* 
-
.31** 
-
.32** -.17 -.07 
-
.26** -.10 .01 -.01 -.38 -.25* 
-
.38** -.25* 
-
.32** -.18 
-
.37** -.27* 
-
.29** -.11 
-
.29** -.33 
-
.32** 
-
.37** -.23* -.20 -.20* 
-
.30** .10 .43** .17 .27* .22* .23* .18 .11 .125 -.11 -.16    
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Table 3. Results of the confirmatory factor analysis in the no pain, acute pain and chronic pain groups in Study 2. Underlined values exceeded the desired cut off point. * = p < .001. 
 χ2 df GFI AGFI CFI RMSEA 
Pain free 432.70* 35 .906 .852 .961 .109 
Acute pain 134.10* 35 .919 .873 .966 .099 
Chronic pain 152.76* 35 .903 .848 .959 .108 
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Table 4. Correlations between measures administered in Study 3, *p<.05, **p<.01. 
 
  
CIP Current pain intensity 
Average pain 
previous week PDI 
Current 
disability PCS total 
PCS 
rumination 
PCS 
magnification 
PCS 
helplessness 
DASS 
depression DASS anxiety DASS stress BVS STAI-T SWLS ERQ reappraisal 
 
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
No 
pain  Pain  
  
Current pain 
intensity .25 .41** 
                              Average pain 
previous 
week 
.21 .30* 
.81** .68** 
                            PDI - .44** - .54** - .57** 
                          Current 
disability - .44** - .79** - .70** - .60** 
                        PCS total .73** .78** .37** .45** .34* .43** - .35* - .42** 
                      PCS 
rumination .68** .72** .21 .42** .19 .43** - .36* - .38** .91** .90** 
                    PCS 
magnification .60** .66** .45** .39** .40** .29* - .22 - .33* .88** .85** .67** .71** 
                  PCS 
helplessness .71** .72** .41** .41** .38** .41** - .33* - .41** .96** .94** .80** .74** .84** .69** 
                DASS 
anxiety .08 .57** .13 .50** .17 .45** - .44** - .47** .35* .59** .29* .45** .33* .64** .35* .54** 
              DASS stress .02 .39** .34* .32* .33* .25 - .25 - .34* .31* .56** .26 .42** .27 .56** .32* .53** .65** .66** 
            DASS 
depression .08 .63** .18 .47** .18 .44** - .45** - .57** .39** .66** .42** .56** .26 .56** .37** .63** .86** .55** .71** .59** 
          BVS .12 .40** -.03 .15 .07 .14 - .27 - .21 .27 .40** .26 .28 .20 .37** .28 .41** .17 .55** .07 .50** .10 .34* 
        STAI-T .39** .60** .37** .31* .32* .21 - .17 - .27 .55** .68** .54** .60** .43 .63** .52** .62** .13** .55** .61** .59** .70** .71** .25 .30* 
      SWLS -.11 -.35* -.19 
-
.45** -.16 
-
.40** - -.35* - 
-
.52** -.24 
-
.44** -.30* 
-
.46** -.11 -.30* -.22 
-
.41** -.36* -.17 -.32* -.25 
-
.50** 
-
.60** -.22 -.01 
-
.64** 
-
.47** 
    ERQ 
reappraisal .06 .08 .14 -.08 .21 -.15 - .18 - -.17 .09 .02 .06 .07 .05 -.08 .13 .04 .10 -.01 .12 -.10 .13 .02 .18 .30* -.05 -.06 -.10 .11 
  ERQ 
suppression .37** .47** -.18 .33* -.24 .25 - .09 - .32 .18 .42** .27 .32* -.01 .38** .17 .41** -.17 .36* -.23 .26 -.10 .36* -.10 0.00 -.12 .48** .03 -.19 .12 -.06 
 
